GLWL-01

N/A

Report date: 2022/08/29 20:00:24
NME

Base Information

Drug NameGLWL-01
Drug Alias NameGLWL-01
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionGhrelin O-acyltransferase inhibitors
TargetsGhrelin O-acyltransferase
Therapy Area/IndicationsAlcoholismDiabetes Mellitus, Type 2Prader-Willi Syndrome
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanadaUnited States
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesEli Lilly And Company
China Registration ClassN/A

Develop Information

Active CompaniesNational Institute On Drug Abuse
Inactive CompaniesGlwl Research Inc
Active IndicationsAlcoholism
Inactive IndicationsDiabetes Mellitus, Type 2Prader-Willi Syndrome

Other Information

ATC CodeN/A
Related LinksN/A